USCA RIA’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$369K Sell
17,195
-3,130
-15% -$63.2K 0.02% 442
2021
Q1
$401K Sell
20,325
-14,626
-42% -$301K 0.03% 409
2020
Q4
$690K Buy
34,951
+10
+0% +$185 0.05% 279
2020
Q3
$614K Buy
+34,941
New +$626K 0.05% 263
2016
Q4
Sell
-17,880
Closed -$335K 384
2016
Q3
$335K Sell
17,880
-1,300
-7% -$24.5K 0.06% 296
2016
Q2
$330K Buy
+19,180
New +$354K 0.06% 288
2016
Q1
Sell
-35,879
Closed -$848K 373
2015
Q4
$848K Buy
35,879
+6,766
+23% +$168K 0.18% 155
2015
Q3
$655K Buy
29,113
+1,304
+5% +$36.5K 0.16% 162
2015
Q2
$784K Buy
27,809
+17,957
+182% +$498K 0.21% 141
2015
Q1
$272K Sell
9,852
-16,050
-62% -$438K 0.07% 267
2014
Q4
$644K Buy
25,902
+4,456
+21% +$107K 0.18% 145
2014
Q3
$474K Buy
21,446
+9,926
+86% +$216K 0.14% 173
2014
Q2
$239K Buy
11,520
+261
+2% +$5.48K 0.08% 249
2014
Q1
$245K Sell
11,259
-65
-0.6% -$1.45K 0.09% 231
2013
Q4
$231K Buy
11,324
+210
+2% +$4.07K 0.09% 221
2013
Q3
$214K Buy
+11,114
New +$213K 0.1% 223

Other funds holding HQL

USCA RIA's HQL Position: Q2 2021 in Review

USCA RIA reduced its abrdn Life Sciences Investors (HQL) stake by 15% in Q2 2021, selling an estimated $63.2K and leaving 17,195 shares worth $369K. The position accounts for 0.02% of the portfolio, ranked #442.

USCA RIA first reported a position in HQL in Q3 2013 and has held it in 16 quarters since. The position peaked at $848K in Q4 2015. 67 funds tracked by Wall St. Rank hold HQL as of Q2 2021.

  • USCA RIA held 17,195 shares of abrdn Life Sciences Investors worth $369K as of Q2 2021.
  • USCA RIA sold 3,130 abrdn Life Sciences Investors shares in Q2 2021, an estimated $63.2K.
  • abrdn Life Sciences Investors made up 0.02% of USCA RIA's portfolio in Q2 2021, its #442 holding.
  • USCA RIA first reported a position in abrdn Life Sciences Investors in Q3 2013 and has held it in 16 quarters since.
  • USCA RIA's abrdn Life Sciences Investors position peaked at $848K in Q4 2015.
  • 67 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2021.

Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.